H.I.G. Closes BioVectra Purchase

The American private equity group H.I.G. Capital said it has completed its US$250 million purchase of Charlottetown-based Biovectra, which makes ingredients for drugs.
The private equity fund, which has $34 billion under management, issued a statement on Monday saying one of its affiliates completed the purchase from Mallinckrodt Pharmaceuticals, of the U.K. Mallinckrodt said in September it had